These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 21813122)

  • 1. Bisphenol A exposure reduces the estradiol response to gonadotropin stimulation during in vitro fertilization.
    Bloom MS; Kim D; Vom Saal FS; Taylor JA; Cheng G; Lamb JD; Fujimoto VY
    Fertil Steril; 2011 Sep; 96(3):672-677.e2. PubMed ID: 21813122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary bisphenol A concentrations and early reproductive health outcomes among women undergoing IVF.
    Ehrlich S; Williams PL; Missmer SA; Flaws JA; Ye X; Calafat AM; Petrozza JC; Wright D; Hauser R
    Hum Reprod; 2012 Dec; 27(12):3583-92. PubMed ID: 23014629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary bisphenol A concentrations and ovarian response among women undergoing IVF.
    Mok-Lin E; Ehrlich S; Williams PL; Petrozza J; Wright DL; Calafat AM; Ye X; Hauser R
    Int J Androl; 2010 Apr; 33(2):385-93. PubMed ID: 20002217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unilateral oophorectomy results in compensatory follicular recruitment in the remaining ovary at time of ovarian stimulation for in vitro fertilization.
    Khan Z; Gada RP; Tabbaa ZM; Laughlin-Tommaso SK; Jensen JR; Coddington CC; Stewart EA
    Fertil Steril; 2014 Mar; 101(3):722-7. PubMed ID: 24355047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response to ovulation trigger is correlated to late follicular phase progesterone levels: A hypothesis explaining reduced reproductive outcomes caused by increased late follicular progesterone rise.
    Friis Wang N; Skouby SO; Humaidan P; Andersen CY
    Hum Reprod; 2019 May; 34(5):942-948. PubMed ID: 30927415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary bisphenol A concentrations and association with in vitro fertilization outcomes among women from a fertility clinic.
    Mínguez-Alarcón L; Gaskins AJ; Chiu YH; Williams PL; Ehrlich S; Chavarro JE; Petrozza JC; Ford JB; Calafat AM; Hauser R;
    Hum Reprod; 2015 Sep; 30(9):2120-8. PubMed ID: 26209788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diminished intrafollicular estradiol levels in in vitro fertilization cycles from women with reduced ovarian response to recombinant human follicle-stimulating hormone.
    Foong SC; Abbott DH; Lesnick TG; Session DR; Walker DL; Dumesic DA
    Fertil Steril; 2005 May; 83(5):1377-83. PubMed ID: 15866572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of low-dose human chorionic gonadotropin combined with human menopausal gonadotropin protocol on women with hypogonadotropic hypogonadism undergoing ovarian stimulation for in vitro fertilization.
    Jiang S; Kuang Y
    Clin Endocrinol (Oxf); 2018 Jan; 88(1):77-87. PubMed ID: 28960429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gonadotropin-releasing hormone antagonist use is associated with increased pregnancy rates in ovulation induction-intrauterine insemination to in vitro fertilization conversions, independent of age and estradiol level on the day of human chorionic gonadotropin administration.
    Quaas AM; Missmer SA; Ginsburg ES
    Fertil Steril; 2010 Feb; 93(2):605-8. PubMed ID: 19324340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the adequacy of gonadotropin-releasing hormone agonist leuprolide to trigger oocyte maturation and management of inadequate response.
    Chang FE; Beall SA; Cox JM; Richter KS; DeCherney AH; Levy MJ
    Fertil Steril; 2016 Oct; 106(5):1093-1100.e3. PubMed ID: 27341988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A simplified universal approach to COH protocol for IVF: ultrashort flare GnRH-agonist/GnRH-antagonist protocol with tailored mode and timing of final follicular maturation.
    Orvieto R
    J Ovarian Res; 2015 Nov; 8():69. PubMed ID: 26536862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Programming in vitro fertilization retrievals during working days after a gonadotropin-releasing hormone antagonist protocol with estrogen pretreatment: does the length of exposure to estradiol impact on controlled ovarian hyperstimulation outcomes?
    Guivarc'h-Levêque A; Homer L; Arvis P; Broux PL; Moy L; Priou G; Vialard J; Colleu D; Dewailly D
    Fertil Steril; 2011 Oct; 96(4):872-6. PubMed ID: 21868004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome.
    Moon HS; Joo BS; Moon SE; Lee SK; Kim KS; Koo JS
    Fertil Steril; 2008 Dec; 90(6):2172-8. PubMed ID: 18439601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary bisphenol A concentration is correlated with poorer oocyte retrieval and embryo implantation outcomes in patients with tubal factor infertility undergoing in vitro fertilisation.
    Shen J; Kang Q; Mao Y; Yuan M; Le F; Yang X; Xu X; Jin F
    Ecotoxicol Environ Saf; 2020 Jan; 187():109816. PubMed ID: 31648075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initiation of ovarian stimulation independent of the menstrual cycle: a case-control study.
    Buendgen NK; Schultze-Mosgau A; Cordes T; Diedrich K; Griesinger G
    Arch Gynecol Obstet; 2013 Oct; 288(4):901-4. PubMed ID: 23545834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The significance of antral follicle size prior to stimulation in predicting ovarian response in a multiple dose GnRH antagonist protocol.
    Lai Q; Chen C; Zhang Z; Zhang S; Yu Q; Yang P; Hu J; Wang CY
    Int J Clin Exp Pathol; 2013; 6(2):258-66. PubMed ID: 23330011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of the efficiency of controlled ovarian hyperstimulation in the gonadotropin-releasing hormone agonist-suppression cycle using the initial follicle count during gonadotropin stimulation.
    Huang FJ; Chang SY; Tsai MY; Kung FT; Wu JF; Chang HW
    J Assist Reprod Genet; 2001 Feb; 18(2):91-6. PubMed ID: 11285987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 450 IU versus 600 IU gonadotropin for controlled ovarian stimulation in poor responders: a randomized controlled trial.
    Lefebvre J; Antaki R; Kadoch IJ; Dean NL; Sylvestre C; Bissonnette F; Benoit J; Ménard S; Lapensée L
    Fertil Steril; 2015 Dec; 104(6):1419-25. PubMed ID: 26361207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimal stimulation IVF using clomiphene citrate and oral contraceptive pill pretreatment for LH suppression.
    Branigan EF; Estes MA
    Fertil Steril; 2000 Mar; 73(3):587-90. PubMed ID: 10689017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized controlled trial of increasing recombinant follicle-stimulating hormone after initiating a gonadotropin-releasing hormone antagonist for in vitro fertilization-embryo transfer.
    Propst AM; Bates GW; Robinson RD; Arthur NJ; Martin JE; Neal GS
    Fertil Steril; 2006 Jul; 86(1):58-63. PubMed ID: 16753156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.